Loading clinical trials...

COMPLETEDPhase 1NCT04292626

Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose

The study should evaluate the biological distribution of 99mTc-1-thio-D-glucose in patients with Hodgkin Lymphoma and Non Hodgkin Lymphoma. The primary objective are: 1. To assess the distribution o...

Lead sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

NCT04638790 · Hodgkin Lymphoma, Adult

UNKNOWNPhase 2

Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

NCT04758650 · Solid Malignancy Located in the Head and Neck, Cancer, and more

UNKNOWNNA

Physical Capacity in Hodgkin Lymphoma Survivors

NCT04636255 · Hodgkin Lymphoma, Adult, Cardiovascular Diseases, and more

UNKNOWN

Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

NCT03535948 · Hodgkin Lymphoma, Adult

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 1, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment16

Start dateJan 2020

Last updatedApr 1, 2021

Condition

Hodgkin Lymphoma, Adult Non-Hodgkin Lymphoma, Adult

Locations shown

TomskNRMC

Tomsk

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 1, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions